Cost of Disease Progression in Patients With Metastatic Breast, Lung, and Colorectal Cancer

Oncologist - United States
doi 10.1634/theoncologist.2018-0018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Association of Serum Progranulin Levels With Disease Progression and Decreased Survival in Metastatic Breast Cancer Patients

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Disease-Free Survival in Patients With Non-Metastatic Breast Cancer

Revista da Associacao Medica Brasileira
Medicine
2016English

Thymidine Phosphorylase Expression Is Associated With Time to Progression in Patients With Metastatic Colorectal Cancer

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2014English

Pretreatment Immune Status Correlates With Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients

Cancer immunology research
Cancer ResearchImmunology
2016English

Prolonged Survival of Patients Receiving Trastuzumab Beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2005English

Burden of Symptoms Associated With Development of Metastatic Bone Disease in Patients With Breast Cancer

Supportive Care in Cancer
Oncology
2016English

Transarterial Chemoembolisation in the Treatment of Patients With Metastatic Colorectal Cancer

I.P. Pavlov Russian Medical Biological Herald
2018English

Major Surgery in Patients With Metastatic Colorectal Cancer in Western Europe

Journal of Gastrointestinal Cancer
OncologyGastroenterology
2011English

Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy